Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohnʼs disease with normal C-reactive protein serum level
Authors:
Open Access
- 1 September 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 13 (9) , 1100-1105
Abstract
Background. Patients with clinically active Crohn's disease (CD), defined by a Crohn's Disease Activity Index (CDAI) >150, may have normal C-reactiveKeywords
This publication has 28 references indexed in Scilit:
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Polymorphisms within the C-Reactive Protein (CRP) Promoter Region Are Associated with Plasma CRP LevelsThe American Journal of Human Genetics, 2005
- Relation of polymorphism within the C-reactive protein gene and plasma CRP levelsAtherosclerosis, 2005
- Genetic variation in DLG5 is associated with inflammatory bowel diseaseNature Genetics, 2004
- Functional variants of OCTN cation transporter genes are associated with Crohn diseaseNature Genetics, 2004
- The genetics of inflammatory bowel diseaseGastroenterology, 2003
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseNature, 2001
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseNature, 2001
- A simple method for assessing intestinal inflammation in Crohn's diseaseGut, 2000
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980